163 related articles for article (PubMed ID: 21257829)
1. Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial.
King A; Bath PM; Markus HS
Stroke; 2011 Mar; 42(3):650-5. PubMed ID: 21257829
[TBL] [Abstract][Full Text] [Related]
2. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study.
Wang X; Lin WH; Zhao YD; Chen XY; Leung TW; Chen C; Fu J; Markus H; Hao Q; Wong KS;
Int J Stroke; 2013 Dec; 8(8):663-8. PubMed ID: 22883712
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
[TBL] [Abstract][Full Text] [Related]
7. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
de Borst GJ; Hilgevoord AA; de Vries JP; van der Mee M; Moll FL; van de Pavoordt HD; Ackerstaff RG
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):135-42. PubMed ID: 17521930
[TBL] [Abstract][Full Text] [Related]
8. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
9. Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study.
Lau AY; Zhao Y; Chen C; Leung TW; Fu J; Huang Y; Suwanwela NC; Han Z; Tan KS; Ratanakorn D; Markus HS; Wong KS;
Int J Stroke; 2014 Oct; 9 Suppl A100():127-32. PubMed ID: 23489888
[TBL] [Abstract][Full Text] [Related]
10. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
Hills NK; Johnston SC
Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
13. High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
Van Der Heyden J; Van Werkum J; Hackeng CM; Kelder JC; Breet NJ; Deneer VH; Ackerstaff RG; Tromp SC; De Vries JP; Vos JA; Suttorp MJ; Elsenberg EH; Van Neerven D; Schonewille WJ; Wolters F; Ten Berg JM
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):337-47. PubMed ID: 23138609
[TBL] [Abstract][Full Text] [Related]
14. Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke.
Goertler M; Blaser T; Krueger S; Hofmann K; Baeumer M; Wallesch CW
J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):338-42. PubMed ID: 11861691
[TBL] [Abstract][Full Text] [Related]
15. The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
Deng QQ; Tang J; Chen C; Markus H; Huang YN; Zhao H; Ratanakorn D; Wong KS; Fu JH
J Neurol Sci; 2016 Aug; 367():18-21. PubMed ID: 27423556
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Fletcher S; Weaver C; Leonardi-Bee J; May J; Fox S; Willmot M; Heptinstal S; Bath P
Thromb Haemost; 2005 Mar; 93(3):527-34. PubMed ID: 15735805
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.
Wang Y; Pan Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Meng X; Wang A; Wang C; Wang Y;
Circulation; 2015 Jul; 132(1):40-6. PubMed ID: 25957224
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of dual antiplatelet therapy in cerebrovascular disease as demonstrated by a decline in microembolic signals. A report of eight cases.
Esagunde RU; Wong KS; Lee MP; Gan HY; Wong MC; Chang HM; Chen CL
Cerebrovasc Dis; 2006; 21(4):242-6. PubMed ID: 16446537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
